Michael Higgins
Stock Analyst at Ladenburg Thalmann
(1.81)
# 3,180
Out of 5,182 analysts
22
Total ratings
33.33%
Success rate
5.24%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $13.50 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $26.74 | +157.11% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $2.69 | +160.22% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $1.00 | +1,400.00% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $1,080 | $3.77 | +28,547.21% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $85.20 | -58.92% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $21.50 | +132.56% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $2,470 → $1,520 | $1.02 | +148,919.61% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $8.07 | +1,201.12% | 2 | Aug 5, 2020 | |
| VIRT Virtu Financial | Upgrades: Buy | $29 | $47.64 | -39.13% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $5.16 | - | 1 | Sep 27, 2017 |
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $13.50
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $26.74
Upside: +157.11%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $2.69
Upside: +160.22%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.00
Upside: +1,400.00%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $1,080
Current: $3.77
Upside: +28,547.21%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $85.20
Upside: -58.92%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $21.50
Upside: +132.56%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $2,470 → $1,520
Current: $1.02
Upside: +148,919.61%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $8.07
Upside: +1,201.12%
Virtu Financial
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $47.64
Upside: -39.13%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $5.16
Upside: -